The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackRock Smaller Companies Trust PLC Regulatory News (BRSC)

Share Price Information for BlackRock Smaller Companies Trust PLC (BRSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,440.00
Bid: 1,438.00
Ask: 1,442.00
Change: 6.00 (0.42%)
Spread: 4.00 (0.278%)
Open: 1,440.00
High: 1,442.00
Low: 1,438.00
Prev. Close: 1,434.00
BRSC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

16 Oct 2018 14:48

BlackRock Smaller Companies Trust Plc - Portfolio Update

BlackRock Smaller Companies Trust Plc - Portfolio Update

PR Newswire

London, October 16

BLACKROCK SMALLER COMPANIES TRUST PLC (LEI: 549300MS535KC2WH4082) 

All information is at 30 September 2018 and unaudited.Performance at month end is calculated on a capital only basis

One month %Three months %One year %Three years %Five years %
Net asset value*-1.7-3.010.655.792.0
Share price*-3.4-6.515.463.387.8
Numis ex Inv Companies + AIM Index-1.2-1.70.526.831.4

*performance calculations based on a capital only NAV with debt at par, without income reinvested. Share price performance calculations exclude income reinvestment.Sources: BlackRock and Datastream

At month end
Net asset value Capital only(debt at par value):1,575.15p
Net asset value Capital only(debt at fair value):1,568.34p
Net asset value incl. Income(debt at par value)**:1,598.31p
Net asset value incl. Income(debt at fair value)**:1,591.51p
Share price1,435.00p
Discount to Cum Income NAV (debt at par value):10.2%
Discount to Cum Income NAV (debt at fair value):9.8%
Net yield^^^:1.8%
Gross assets^:£840.0m
Gearing range as a % of net assets:0-15%
Net gearing including income (debt at par):7.0%
2018 Ongoing charges ratio^^0.7%
2018 Ongoing charges ratio (including performance fees):1.0%
Ordinary shares in issue#:47,879,792

**includes net revenue of 23.16p

^includes current year revenue

^^As reported in the Annual Financial Report for the year ended 28 February 2018, the ongoing charges ratio is calculated as a percentage of net assets and using operating expenses, excluding performance fees, finance costs and taxation.

^^^Yield calculations are based on dividends announced in the last 12 months as at the date of release of this announcement, and comprise of the final dividend of 16.00 pence per share, (announced on 27 April 2018, ex-dividend on 17 May 2018) and the interim dividend of 10.00 pence per share (announced on 30 October 2017 and gone ex-dividend on 9 November 2017).

#excludes 2,113,731 shares held in treasury.

Sector Weightings% of portfolio
Industrials31.3
Financials21.1
Consumer Services12.0
Consumer Goods8.2
Health Care7.3
Technology7.3
Oil & Gas6.3
Basic Materials6.0
Utilities0.5
-----
Total100.0
=====

Ten Largest Equity Investments
Company% of portfolio
Robert Walters1.9
4imprint Group1.9
YouGov1.8
Integrafin1.8
Big Yellow1.6
Premier Asset Management Group1.6
Central Asia Metals1.5
Accesso Technology1.5
Bodycote1.5
Polar Capital Holdings1.5

Commenting on the markets, Mike Prentis, representing the Investment Manager noted:During September the Company’s NAV per share fell by 1.7% to 1,575.15p on a capital only basis, underperforming the benchmark index which fell by 1.2%; the FTSE 100 Index rose by 1.0% on a capital only basis.

September continued to be a difficult month for the Company. In general, the portfolio holdings have continued to trade well, however we have also suffered some stock specific disappointments; the main detractors were Dechra Pharmaceuticals and Alliance Pharma.

Shares in Dechra Pharmaceuticals fell in response to a small earnings downgrade due to the additional cost incurred from Brexit contingency planning. Speciality pharmaceuticals group Alliance Pharma fell after reporting half-year revenues up by 4%, slightly behind expectations. In both cases, a modest disappointment has led to much larger share price falls, detracting 0.6% and 0.3% from relative performance respectively. We still like these companies on a medium-term basis.

Learning Technologies was the largest positive contributor to performance after the company’s half year results beat expectations. The company is involved in the provision of e-learning services and through recent acquisitions has built a strong platform that is well placed to drive further growth.

We have continued to reduce or sell holdings where our conviction has weakened, and added to holdings where we continue to have confidence in the strength of the underlying businesses in the current environment including IG Design and Big Yellow.

Since the month end, markets have fallen sharply, driven by a variety of concerns: rising US bond yields and expectations of further US interest rate increases, global trade wars, the Italian economy and plans to increase the budget deficit, and next Brexit steps. We have seen a large style reversal with growth and high momentum stocks sold off, whereas value shares have held up better, having performed poorly for some time. This has not suited our portfolio. However, we hold our companies because of their long-term growth attractions and the strength of their management teams; these are undiminished.

16 October 2018ENDS 

Latest information is available by typing www.blackrock.co.uk/brsc on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). Neither the contents of the Manager’s website nor the contents of any website accessible from hyperlinks on the Manager’s website (or any other website) is incorporated into, or forms part of, this announcement.

Date   Source Headline
7th May 202412:35 pmPRNNet Asset Value(s)
3rd May 202412:14 pmPRNNet Asset Value(s)
2nd May 202412:10 pmPRNNet Asset Value(s)
1st May 20246:05 pmPRNTotal Voting Rights
1st May 202412:11 pmPRNNet Asset Value(s)
30th Apr 20243:01 pmPRNPortfolio Update Correction
30th Apr 202412:08 pmPRNNet Asset Value(s)
29th Apr 202412:26 pmPRNNet Asset Value(s)
29th Apr 202410:35 amPRNPortfolio Update
26th Apr 202411:46 amPRNNet Asset Value(s)
25th Apr 20245:19 pmPRNHolding(s) in Company
25th Apr 202412:15 pmPRNNet Asset Value(s)
24th Apr 202412:15 pmPRNNet Asset Value(s)
23rd Apr 202412:13 pmPRNNet Asset Value(s)
22nd Apr 202411:54 amPRNNet Asset Value(s)
19th Apr 202412:07 pmPRNNet Asset Value(s)
18th Apr 202412:17 pmPRNNet Asset Value(s)
18th Apr 20247:00 amPRNTotal Voting Rights
17th Apr 202412:14 pmPRNNet Asset Value(s)
17th Apr 20247:00 amPRNTotal Voting Rights
16th Apr 20245:40 pmPRNTransaction in Own Shares
16th Apr 202412:02 pmPRNNet Asset Value(s)
16th Apr 20247:00 amPRNTotal Voting Rights
15th Apr 20245:53 pmPRNTransaction in Own Shares
15th Apr 202411:38 amPRNNet Asset Value(s)
12th Apr 20246:52 pmPRNTransaction in Own Shares
12th Apr 202412:15 pmPRNNet Asset Value(s)
11th Apr 202412:43 pmPRNHolding(s) in Company
11th Apr 202412:12 pmPRNNet Asset Value(s)
11th Apr 20247:00 amPRNTotal Voting Rights
10th Apr 202412:07 pmPRNNet Asset Value(s)
10th Apr 20247:00 amPRNTotal Voting Rights
9th Apr 20245:47 pmPRNTransaction in Own Shares
9th Apr 202411:45 amPRNNet Asset Value(s)
9th Apr 20247:00 amPRNTotal Voting Rights
8th Apr 20245:59 pmPRNTransaction in Own Shares
8th Apr 202412:00 pmPRNNet Asset Value(s)
8th Apr 20247:00 amPRNTotal Voting Rights
5th Apr 20245:45 pmPRNTransaction in Own Shares
5th Apr 202412:15 pmPRNNet Asset Value(s)
5th Apr 20247:00 amPRNTotal Voting Rights
4th Apr 20245:46 pmPRNTransaction in Own Shares
4th Apr 202412:03 pmPRNNet Asset Value(s)
4th Apr 20247:00 amPRNTotal Voting Rights
3rd Apr 20245:34 pmPRNTransaction in Own Shares
3rd Apr 202412:08 pmPRNNet Asset Value(s)
3rd Apr 20247:00 amPRNTotal Voting Rights
3rd Apr 20247:00 amPRNTransaction in Own Shares
2nd Apr 20241:00 pmPRNMandatory Closed Period Compliance with MAR
2nd Apr 202412:08 pmPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.